{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:12:42Z","timestamp":1790647962716,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology Plus"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.mbplus.2021.100095","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T02:54:20Z","timestamp":1638413660000},"page":"100095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Targeting the \u201csweet spot\u201d in septic shock \u2013 A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2"],"prefix":"10.1016","volume":"12","author":[{"given":"Thorben","family":"Pape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Hunkem\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"K\u00fcmpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mbplus.2021.100095_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mbplus.2021.100095_b0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imj.14199","article-title":"Sepsis and septic shock: current approaches to management","volume":"49","author":"Thompson","year":"2019","journal-title":"Int. Med. J."},{"key":"10.1016\/j.mbplus.2021.100095_b0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","article-title":"Epidemiology of sepsis in Germany: results from a national prospective multicenter study","volume":"33","author":"Engel","year":"2007","journal-title":"Intensive Care Med."},{"issue":"10219","key":"10.1016\/j.mbplus.2021.100095_b0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mbplus.2021.100095_b0030","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","article-title":"Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study","volume":"42","author":"SepNet Critical Care Trials Group","year":"2016","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing sepsis as a global health priority \u2014 a WHO resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mbplus.2021.100095_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13613-015-0058-8","article-title":"Timing and causes of death in septic shock","volume":"5","author":"Daviaud","year":"2015","journal-title":"Ann. Intensive Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0045","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mbplus.2021.100095_b0050","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","article-title":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome","volume":"101","author":"Aird","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.201061","article-title":"Mending leaky blood vessels: the angiopoietin-Tie2 pathway in sepsis","volume":"345","author":"David","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mbplus.2021.100095_b0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"The endothelium in sepsis","volume":"45","author":"Ince","year":"2016","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.mbplus.2021.100095_b0065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","article-title":"Harmful molecular mechanisms in sepsis","volume":"8","author":"Rittirsch","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mbplus.2021.100095_b0070","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3389\/fimmu.2019.02536","article-title":"DAMPs and NETs in sepsis","volume":"10","author":"Denning","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mbplus.2021.100095_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/SHK.0b013e318276f4ca","article-title":"Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates","volume":"39","author":"Sursal","year":"2013","journal-title":"Shock."},{"key":"10.1016\/j.mbplus.2021.100095_b0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SHK.0b013e318277109c","article-title":"DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis","volume":"39","author":"Gentile","year":"2013","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.mbplus.2021.100095_b0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12331","article-title":"Endothelial barrier dysfunction in septic shock","volume":"277","author":"Opal","year":"2015","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaci.2016.10.042","article-title":"Idiopathic systemic capillary leak syndrome (Clarkson disease)","volume":"140","author":"Druey","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jth.14371","article-title":"Derangement of the endothelial glycocalyx in sepsis","volume":"17","author":"Iba","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.mbplus.2021.100095_b0110","doi-asserted-by":"crossref","first-page":"13591","DOI":"10.1038\/s41598-019-50068-5","article-title":"Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling","volume":"9","author":"Kiyan","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.mbplus.2021.100095_b0115","first-page":"1071","article-title":"Structure and functions of syndecans in vertebrates","volume":"78","author":"Leonova","year":"2013","journal-title":"Biochem."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch \u2013 Eur J Physiol"},{"key":"10.1016\/j.mbplus.2021.100095_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40560-016-0182-z","article-title":"Glycocalyx and its involvement in clinical pathophysiologies","volume":"4","author":"Ushiyama","year":"2016","journal-title":"J. Intensive Care"},{"issue":"7","key":"10.1016\/j.mbplus.2021.100095_b0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/anae.12661","article-title":"The endothelial glycocalyx: a review of the vascular barrier","volume":"69","author":"Alphonsus","year":"2014","journal-title":"Anaesthesia."},{"key":"10.1016\/j.mbplus.2021.100095_b0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit. Care."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0140","doi-asserted-by":"crossref","first-page":"H508","DOI":"10.1152\/ajpheart.1999.277.2.H508","article-title":"Permeation of the luminal capillary glycocalyx is determined by hyaluronan","volume":"277","author":"Henry","year":"1999","journal-title":"Am. J. Physiol. \u2013 Hear. Circ. Physiol."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2007.01.137","article-title":"The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress","volume":"355","author":"Pahakis","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cvr\/cvq137","article-title":"Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential","volume":"87","author":"Becker","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0155","doi-asserted-by":"crossref","first-page":"H1672","DOI":"10.1152\/ajpheart.00832.2003","article-title":"Inflammation- and ischemia-induced shedding of venular glycocalyx","volume":"286","author":"Mulivor","year":"2004","journal-title":"Am. J. Physiol. \u2013 Hear. Circ. Physiol."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100095_b0160","doi-asserted-by":"crossref","first-page":"H2235","DOI":"10.1152\/ajpheart.00803.2011","article-title":"Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammation","volume":"301","author":"Lipowsky","year":"2011","journal-title":"Am. J. Physiol. Circ. Physiol."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100095_b0165","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00117.2002","article-title":"Role of glycocalyx in leukocyte-endothelial cell adhesion","volume":"283","author":"Mulivor","year":"2002","journal-title":"Am. J. Physiol. Circ. Physiol."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100095_b0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","article-title":"Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface","volume":"23","author":"Constantinescu","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"21","key":"10.1016\/j.mbplus.2021.100095_b0175","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1111\/jcmm.15895","article-title":"The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis","volume":"24","author":"Lupu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/ATVBAHA.119.313399","article-title":"Shear stress regulation of endothelial glycocalyx structure is determined by glucobiosynthesis","volume":"40","author":"Wang","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0185","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/HYPERTENSIONAHA.114.05119","article-title":"Characteristics and determinants of the sublingual microcirculation in populations of different ethnicity","volume":"65","author":"Gu","year":"2015","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.mbplus.2021.100095_b0190","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.mbplus.2021.100095_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/phy2.153","article-title":"Heparanase mediates renal dysfunction during early sepsis in mice","volume":"1","author":"Lygizos","year":"2013","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2008.03.024","article-title":"Tumor necrosis factor-\u03b1 inhibition protects against endotoxin-induced endothelial glycocalyx perturbation","volume":"202","author":"Nieuwdorp","year":"2009","journal-title":"Atherosclerosis."},{"issue":"9","key":"10.1016\/j.mbplus.2021.100095_b0205","doi-asserted-by":"crossref","first-page":"F956","DOI":"10.1152\/ajprenal.00532.2014","article-title":"A microscopic view on the renal endothelial glycocalyx","volume":"308","author":"Dane","year":"2015","journal-title":"Am. J. Physiol. \u2013 Ren. Physiol."},{"issue":"3-4","key":"10.1016\/j.mbplus.2021.100095_b0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00508-019-01592-x","article-title":"Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival","volume":"133","author":"Jordakieva","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0215","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc8938","article-title":"Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis","volume":"14","author":"Gaddnas","year":"2010","journal-title":"Crit. Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvx023","article-title":"Endothelial glycocalyx breakdown is mediated by angiopoietin-2","volume":"113","author":"Lukasz","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0225","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/bja\/aer515","article-title":"Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy","volume":"108","author":"Woodcock","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.mbplus.2021.100095_b0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cvr\/cvq062","article-title":"Microvascular fluid exchange and the revised Starling principle","volume":"87","author":"Levick","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mbplus.2021.100095_b0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00000542-200110000-00011","article-title":"Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy","volume":"95","author":"Rehm","year":"2001","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0240","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/cc12532","article-title":"Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines","volume":"17","author":"Ostrowski","year":"2013","journal-title":"Crit. Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13054-015-0918-5","article-title":"Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study","volume":"19","author":"Ostrowski","year":"2015","journal-title":"Crit. Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SHK.0b013e3181777da3","article-title":"Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma","volume":"30","author":"Nelson","year":"2008","journal-title":"Shock."},{"issue":"10-11","key":"10.1016\/j.mbplus.2021.100095_b0255","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2016.02.014","article-title":"Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients","volume":"49","author":"Anand","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mbplus.2021.100095_b0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcrc.2016.06.027","article-title":"Plasma syndecan-1 levels identify a cohort of patients with severe sepsis at high risk for intubation after large-volume intravenous fluid resuscitation","volume":"36","author":"Puskarich","year":"2016","journal-title":"J. Crit. Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13054-019-2542-2","article-title":"Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis","volume":"23","author":"Rovas","year":"2019","journal-title":"Crit. Care."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0310057X20916471","article-title":"Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis","volume":"48","author":"Beurskens","year":"2020","journal-title":"Anaesth. Intensive Care."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jss.2009.04.034","article-title":"Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix","volume":"165","author":"Steppan","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.mbplus.2021.100095_b0280","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","article-title":"Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis","volume":"43","author":"Ikeda","year":"2018","journal-title":"J. Crit. Care."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/aas.12223","article-title":"Circulating glycosaminoglycan species in septic shock","volume":"58","author":"Nelson","year":"2014","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jcp.1041480213","article-title":"Heparanase activity in cultured endothelial cells","volume":"148","author":"Godder","year":"1991","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0295","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1091\/mbc.1.11.833","article-title":"Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix","volume":"1","author":"Ishai-Michaeli","year":"1990","journal-title":"Cell Regul."},{"key":"10.1016\/j.mbplus.2021.100095_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3758278","article-title":"The endothelial glycocalyx: new diagnostic and therapeutic approaches in sepsis","volume":"2016","author":"Martin","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.mbplus.2021.100095_b0305","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/978-3-030-34521-1_20","article-title":"Non-anticoagulant heparins as heparanase inhibitors","volume":"1221","author":"Cassinelli","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0310","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","article-title":"The glycocalyx\u2013linking albuminuria with renal and cardiovascular disease","volume":"11","author":"Rabelink","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0315","doi-asserted-by":"crossref","first-page":"e0127584","DOI":"10.1371\/journal.pone.0127584","article-title":"Peptide 19\u20132.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum","volume":"10","author":"Martin","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/ejh.12997","article-title":"Heparanase level and procoagulant activity are reduced in severe sepsis","volume":"100","author":"Matan","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mbplus.2021.100095_b0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40635-021-00417-4","article-title":"Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock","volume":"9","author":"Stahl","year":"2021","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.mbplus.2021.100095_b0330","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2019.01.017","article-title":"Heparanase in health and disease: the neglected housekeeper of the cell?","volume":"283","author":"Shu","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.mbplus.2021.100095_b0335","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/cvr\/cvy167","article-title":"A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation","volume":"114","author":"Yang","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mbplus.2021.100095_b0340","doi-asserted-by":"crossref","first-page":"335ra55","DOI":"10.1126\/scitranslmed.aad9260","article-title":"Amelioration of sepsis by TIE2 activation-induced vascular protection","volume":"8","author":"Han","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mbplus.2021.100095_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575047","article-title":"Increased plasma heparanase activity in COVID-19 Patients","volume":"11","author":"Buijsers","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0350","doi-asserted-by":"crossref","first-page":"e80905","DOI":"10.1371\/journal.pone.0080905","article-title":"Nanomechanics of the endothelial glycocalyx in experimental sepsis","volume":"8","author":"Wiesinger","year":"2013","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0355","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1055\/s-0039-1695768","article-title":"Tie2 activation promotes protection and reconstitution of the endothelial glycocalyx in human sepsis","volume":"119","author":"Drost","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.mbplus.2021.100095_b0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/shk.0b013e3180311d84","article-title":"Heparanase pretreatment attenuates endotoxin-induced acute lung injury in rats","volume":"28","author":"Bashenko","year":"2007","journal-title":"Shock."},{"issue":"10","key":"10.1016\/j.mbplus.2021.100095_b0365","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2009.06.005","article-title":"Heparanase: busy at the cell surface","volume":"34","author":"Fux","year":"2009","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100095_b0370","first-page":"546","article-title":"Sepsis-induced acute kidney injury","volume":"22","author":"G\u00f3mez","year":"2016","journal-title":"Curr. Opin. Crit. Care."},{"issue":"17","key":"10.1016\/j.mbplus.2021.100095_b0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2011.11.057","article-title":"Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance","volume":"59","author":"Baker","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mbplus.2021.100095_b0380","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","article-title":"Heparanase induces tissue factor expression in vascular endothelial and cancer cells","volume":"4","author":"Nadir","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.mbplus.2021.100095_b0385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0037-1608919","article-title":"Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells","volume":"99","author":"Nadir","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0390","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Nadir","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.mbplus.2021.100095_b0395","doi-asserted-by":"crossref","unstructured":"I. Henig, E. Axelman, B. Brenner, I. Vlodavsky, Y. Nadir, Heparanase activation of the coagulation system in a mice sepsis model, Blood. 118 (2011) 378\u2013378. https:\/\/doi.org\/10.1182\/blood.V118.21.378.378.","DOI":"10.1182\/blood.V118.21.378.378"},{"issue":"09","key":"10.1016\/j.mbplus.2021.100095_b0400","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH13-12-1049","article-title":"Novel peptides that inhibit heparanase activation of the coagulation system","volume":"112","author":"Axelman","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0405","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/jth.15266","article-title":"Heparanase expression and activity are increased in platelets during clinical sepsis","volume":"19","author":"Eustes","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100095_b0410","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1369\/0022155417692536","article-title":"Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis","volume":"65","author":"Chen","year":"2017","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mbplus.2021.100095_b0415","first-page":"4903","article-title":"Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mbplus.2021.100095_b0420","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","article-title":"Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression","volume":"33","author":"Blich","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.mbplus.2021.100095_b0425","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI43792","article-title":"Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice","volume":"121","author":"Lerner","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.mbplus.2021.100095_b0430","doi-asserted-by":"crossref","first-page":"e0143583","DOI":"10.1371\/journal.pone.0143583","article-title":"The synthetic antimicrobial peptide 19\u20132.5 interacts with heparanase and heparan sulfate in murine and human sepsis","volume":"10","author":"Martin","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mbplus.2021.100095_b0435","doi-asserted-by":"crossref","unstructured":"J.A. Hippensteel, B.J. Anderson, J.E. Orfila, S.A. McMurtry, R.M. Dietz, G. Su, J.A. Ford, K. Oshima, Y. Yang, F. Zhang, X. Han, Y. Yu, J. Liu, R.J. Linhardt, N.J. Meyer, P.S. Herson, E.P. Schmidt, Circulating heparan sulfate fragments mediate septic cognitive dysfunction, J. Clin. Invest. 129 (2019) 1779\u20131784. https:\/\/doi.org\/10.1172\/JCI124485.","DOI":"10.1172\/JCI124485"},{"issue":"10","key":"10.1016\/j.mbplus.2021.100095_b0440","doi-asserted-by":"crossref","first-page":"e109596","DOI":"10.1371\/journal.pone.0109596","article-title":"Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4","volume":"9","author":"Goodall","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mbplus.2021.100095_b0445","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1074\/jbc.271.27.16139","article-title":"Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence","volume":"271","author":"Lortat-Jacob","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbplus.2021.100095_b0450","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/SHK.0000000000000462","article-title":"Soluble heparan sulfate in serum of septic shock patients induces mitochondrial dysfunction in murine cardiomyocytes","volume":"44","author":"Martin","year":"2015","journal-title":"Shock."},{"issue":"19","key":"10.1016\/j.mbplus.2021.100095_b0455","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1073\/pnas.1902227116","article-title":"Circulating heparin oligosaccharides rapidly target the hippocampus in sepsis, potentially impacting cognitive functions","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0460","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s13311-020-00862-1","article-title":"Septic-associated encephalopathy: a comprehensive review","volume":"17","author":"Mazeraud","year":"2020","journal-title":"Neurotherapeutics."},{"issue":"24","key":"10.1016\/j.mbplus.2021.100095_b0465","doi-asserted-by":"crossref","first-page":"14904","DOI":"10.1074\/jbc.M114.634337","article-title":"Microglial heparan sulfate proteoglycans facilitate the cluster-of-differentiation 14 (CD14)\/toll-like receptor 4 (TLR4)-dependent inflammatory response","volume":"290","author":"O'Callaghan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0470","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1006\/bbrc.2000.3586","article-title":"Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member","volume":"276","author":"McKenzie","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"36","key":"10.1016\/j.mbplus.2021.100095_b0475","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","article-title":"Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity","volume":"285","author":"Levy-Adam","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100095_b0480","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ajhg.2010.05.006","article-title":"Mutations in HPSE2 cause urofacial syndrome","volume":"86","author":"Daly","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2017.10.007","article-title":"Opposing functions of heparanase-1 and heparanase-2 in cancer progression","volume":"43","author":"Vlodavsky","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mbplus.2021.100095_b0490","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1590\/1516-3180.2013.7080003","article-title":"Analysis of heparanase isoforms and cathepsin B in the plasma of patients with gastrointestinal carcinomas: analytical cross-sectional study","volume":"133","author":"Melo","year":"2015","journal-title":"Sao Paulo Med. J."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0495","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.mbplus.2021.100095_b0500","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri3713","article-title":"Assembly and localization of Toll-like receptor signalling complexes","volume":"14","author":"Gay","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.mbplus.2021.100095_b0505","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors \u2013 redefining innate immunity","volume":"13","author":"O'Neill","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0510","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.4049\/jimmunol.181.2.1446","article-title":"Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide","volume":"181","author":"Lloyd-Jones","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.mbplus.2021.100095_b0515","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202007-2676LE","article-title":"Injury to the endothelial glycocalyx in critically ill COVID-19 patients","author":"Stahl","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100095_b0520","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10456-021-09805-6","article-title":"COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects","volume":"24","author":"Smadja","year":"2021","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0525","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10456-020-09753-7","article-title":"Microvascular dysfunction in COVID-19: the MYSTIC study","volume":"24","author":"Rovas","year":"2021","journal-title":"Angiogenesis"},{"issue":"19","key":"10.1016\/j.mbplus.2021.100095_b0530","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy collaborative group, early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0535","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.mbplus.2021.100095_b0540","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/aas.12418","article-title":"Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model","volume":"59","author":"Yini","year":"2015","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.mbplus.2021.100095_b0545","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2017.03.007","article-title":"Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin","volume":"112","author":"Lipowsky","year":"2017","journal-title":"Microvasc. Res."},{"issue":"13","key":"10.1016\/j.mbplus.2021.100095_b0550","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1096\/fj.07-8450com","article-title":"P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins","volume":"21","author":"Hostettler","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.mbplus.2021.100095_b0555","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0706344","article-title":"A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity","volume":"146","author":"Takahashi","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.mbplus.2021.100095_b0560","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/ph10040078","article-title":"Heparin mimetics: their therapeutic potential","volume":"10","author":"Mohamed","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.mbplus.2021.100095_b0565","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10637-010-9388-4","article-title":"A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human \u03b1(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer","volume":"29","author":"Chu","year":"2011","journal-title":"Invest. New Drugs."},{"key":"10.1016\/j.mbplus.2021.100095_b0570","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1038\/srep14292","article-title":"Lipoproteins\/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides","volume":"5","author":"Martinez de Tejada","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mbplus.2021.100095_b0575","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/ijms22031465","article-title":"Anti-infective and anti-inflammatory mode of action of peptide 19\u20132.5","volume":"22","author":"Heinbockel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.mbplus.2021.100095_b0580","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nchembio.1956","article-title":"Functional and structural characterization of a heparanase","volume":"11","author":"Bohlmann","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.mbplus.2021.100095_b0585","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nchembio.2395","article-title":"Activity-based probes for functional interrogation of retaining \u03b2-glucuronidases","volume":"13","author":"Wu","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mbplus.2021.100095_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: A prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit. Care."},{"key":"10.1016\/j.mbplus.2021.100095_b0595","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","article-title":"Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock","volume":"24","author":"Stahl","year":"2020","journal-title":"Crit. Care."},{"issue":"12","key":"10.1016\/j.mbplus.2021.100095_b0600","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1177\/0885066620965169","article-title":"Effect of therapeutic plasma exchange on immunoglobulin deficiency in early and severe septic shock","volume":"36","author":"Stahl","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.mbplus.2021.100095_b0605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13054-018-2289-1","article-title":"To remove and replace-a role for plasma exchange in counterbalancing the host response in sepsis","volume":"23","author":"David","year":"2019","journal-title":"Crit. Care."},{"issue":"1","key":"10.1016\/j.mbplus.2021.100095_b0610","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0828-6","article-title":"Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial","volume":"19","author":"Straat","year":"2015","journal-title":"Crit. Care."}],"container-title":["Matrix Biology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590028521000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590028521000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:00:05Z","timestamp":1762909205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590028521000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":122,"alternative-id":["S2590028521000399"],"URL":"https:\/\/doi.org\/10.1016\/j.mbplus.2021.100095","relation":{},"ISSN":["2590-0285"],"issn-type":[{"value":"2590-0285","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the \u201csweet spot\u201d in septic shock \u2013 A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbplus.2021.100095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100095"}}